You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Annora Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ANNORA, and what generic and branded alternatives to ANNORA drugs are available?

ANNORA has forty-four approved drugs.

There are four tentative approvals on ANNORA drugs.

Summary for Annora

US Patents:	0
Tradenames:	37
Ingredients:	37
NDAs:	44
Patent Litigation for Annora:	See patent lawsuits for Annora

Drugs and US Patents for Annora

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Annora Pharma	VENLAFAXINE HYDROCHLORIDE	venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	212277-003	Jul 8, 2019	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Annora Pharma	SOLIFENACIN SUCCINATE	solifenacin succinate	TABLET;ORAL	215761-001	Jun 15, 2022	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Annora Pharma	DIVALPROEX SODIUM	divalproex sodium	TABLET, EXTENDED RELEASE;ORAL	215527-001	Sep 26, 2023	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Annora Pharma	BUPROPION HYDROCHLORIDE	bupropion hydrochloride	TABLET, EXTENDED RELEASE;ORAL	216800-003	May 31, 2023	AB1	RX	No	No		⤷ Sign Up				⤷ Sign Up
Annora Pharma	FAMOTIDINE	famotidine	TABLET;ORAL	215766-001	Nov 8, 2021		OTC	No	No		⤷ Sign Up				⤷ Sign Up
Annora Pharma	VENLAFAXINE HYDROCHLORIDE	venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	212277-002	Jul 8, 2019	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.